Mast cell leukemia with prolonged survival on PKC412/midostaurin

Xiangdong Xu; Kreisel, Friederike H.; Frater, John L.; Hassan, Anjum
June 2014
International Journal of Clinical & Experimental Pathology;2014, Vol. 7 Issue 6, p3439
Academic Journal
No abstract available.


Related Articles

  • BioTransplant's Medi-507 demonstrates prolonged survival in preclinical model of leukemia.  // PharmaWatch: Cancer;August 2003, Vol. 2 Issue 8, p27 

    Announces that BioTransplant's Medi-507 demonstrated prolonged survival in a murine model of adult T-cell leukemia.

  • High smudge cell percentage associated with prolonged survival in CLL.  // Hem/Onc Today;4/10/2009, Vol. 10 Issue 7, p24 

    The article discusses a study which showed that chronic lymphocytic leukemia patients with a higher percentage of smudge cells had prolonged survival.

  • Mast cell leukemia: a report of ten cases. Valentini, Caterina Giovanna; Rondoni, Michela; Pogliani, Enrico Maria; Van Lint, Maria Teresa; Cattaneo, Chiara; Marbello, Laura; Pulsoni, Alessandro; Giona, Fiorina; Martinelli, Giovanni; Leone, Giuseppe; Pagano, Livio // Annals of Hematology;Jun2008, Vol. 87 Issue 6, p505 

    A letter to the editor about the results of 10 cases of mast cell leukemia is presented.

  • Intratumoral mast cells promote the growth of pancreatic cancer. Ying Ma; Ullrich, Stephen E. // OncoImmunology;Oct2013, Vol. 2 Issue 10, pe25964-1 

    We have recently discovered that mast cells promote pancreatic tumorigenesis by exacerbating the cellular and extracellular signaling in the desmoplastic microenvironment. Our findings demonstrate for the first time that targeting mast cells can block the progression of pancreatic neoplasms and...

  • Low MCL-1 mRNA expression correlates with prolonged survival in B-cell chronic lymphocytic leukemia. Véronèse, L.; Tournilhac, O.; Verrelle, P.; Davi, F.; Dighiero, G.; Chautard, E.; Veyrat-Masson, R.; Kwiatkowski, F.; Goumy, C.; Vago, P.; Travade, P.; Tchirkov, A. // Leukemia (08876924);Jun2008, Vol. 22 Issue 6, p1291 

    A letter to the editor is presented in response to the article "Low MCL-1 mRNA Expression Correlates With Prolonged Survival in B-cell Chronic Lymphocytic Leukemia," in the November 29, 2007 issue.

  • Chronic Leukemia.  // Current Medical Literature: Leukemia & Lymphoma;2010, Vol. 18 Issue 3, p85 

    The article discusses several studies on chronic leukemia (CML), which include "CD19 Targeting of Chronic Lymphocytic Leukemia With a Novel Fc-Domain-Engineered Monoclonal Antibody," "Bortezomib Induces Apoptosis in Primitive Chronic Myeloid Leukemia Cells Including LTC-IC and NOD/SCID...

  • Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor β chain and KIT V654A. Spector, M S; Iossifov, I; Kritharis, A; He, C; Kolitz, J E; Lowe, S W; Allen, S L // Leukemia (08876924);Jun2012, Vol. 26 Issue 6, p1422 

    A letter to the editor is presented which discusses the study on the DNA changes in patient with mast-cell leukemia (MCL) using two approaches.

  • Cladribine therapy in a patient with an aleukemic subvariant of mast cell leukemia. Penack, Olaf; Sotlar, Karl; Noack, Frank; Horny, Hans-Peter; Thiel, Eckhard; Notter, Michael // Annals of Hematology;Oct2005, Vol. 84 Issue 10, p692 

    Presents a letter to the editor regarding the case of patient with an aleukemic subvariant of mast cell leukemia with a very good partial response to cladribine therapy.

  • Acute Leukemia in Adolescents and Adults. Meyers, Muriel G.; Hines, Dale R.; Bishop, Ronald C. // Annals of Internal Medicine;Sep65, Vol. 63 Issue 3, p411 

    Discusses the treatment of acute leukemia in adolescents and adults. Incidence of acute leukemia according to cell type; Survival rate in acute leukemia; Presence of primitive undifferentiated hemocytoblasts.

  • Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa. Hermine, Olivier; Bouscary, Didier; Gessain, Antoine; Turlure, Pascal; Leblond, Veronique; Franck, Nathalie; Buzyn-Veil, Agnes; Rio, Bernard; Macintyre, Elisabeth; Dreyfus, Francois; Bazarbachi, Ali // New England Journal of Medicine;6/29/95, Vol. 332 Issue 26, p1749 

    The article discusses treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. The human T-cell lymphotropic virus type 1 (HTLV-1) causes development of HTLV-1 antibodies in the serum of patients and integration of HTLV-1 proviruses. The different types...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics